ACSL4 and breast neoplasm: Further work will be required to demonstrate that routine measurement of ACSL4 in breast tumor samples might obviate the need for hormone/HER2 receptor measurements in cases where ACSL4 is positive, or be useful as a marker, in addition to receptor status, in making treatment decisions.